Specialty medications already account for a disproportionate share of pharmacy spend and an even larger share of the operational complexity in a health system's pharmacy program, and both numbers are still climbing. A program built to handle today's prescription volume on today's manual coordination is a program that's already behind the curve it's trying to stay ahead of.
What "built for today" usually means in practice
Most specialty pharmacy programs run on a version of the same pattern: benefits verification, prior authorization, and routing happen in sequence, after the prescription is already written, coordinated by a clinical team checking multiple systems that don't share what they know with each other. That pattern is manageable at current volume, staffed by people who've learned to work around the gaps. It's a pattern that breaks down first under volume growth, and second under any regulatory or payer shift that adds a new step to an already sequential process.
Three things leading programs will have that most don't yet
Unified data across the whole prescription journey. Not a dashboard that pulls from the EHR and calls it complete, but a single view spanning payer, pharmacy, and wholesaler data, so a program can see where a prescription actually is, not just where it was when it last touched the EHR.
Why the gap compounds instead of holding steady
A program that's slightly behind on coordination today doesn't stay slightly behind. Every point of friction, a delayed prior auth, a routing decision made too late, an affordability check that surfaces after financial exposure has already started, adds distance between the prescription and the first dose. That distance compounds across a growing volume of specialty scripts, and the clinical team absorbs the difference in the form of follow-up calls and status checks that a better-sequenced program wouldn't generate in the first place.
Where the strain shows up first
The strain of an under-built program rarely announces itself as a single dramatic failure. It shows up first as a slow creep in a handful of specific places: the clinical team's after-hours call volume ticking up because status checks that should resolve during business hours are spilling into evenings, a prescription capture rate that erodes a percentage point at a time without anyone tracing it to a specific cause, and a leadership team fielding more questions than usual about why a competing health system's specialty pharmacy program seems to be growing faster.
What moving coordination upstream actually changes
This is the shift LRx360 is built around: a specialty pharmacy performance enablement platform, co-developed by Longitude Rx and powered by Innovaccer's Gravity Platform, that unifies specialty pharmacy data across payers, pharmacies, and wholesalers and embeds intelligence directly into the workflow from the moment a prescription is written, rather than reconstructing what happened after the fact.
The question worth asking this quarter
Not "is our program handling current volume," which most programs can still answer yes to today. The harder and more useful question: if specialty prescription volume grew 30% next year with no change to how coordination happens, where would the program actually break first, and how much runway does that give before it does.
